Profiles

Keywords
Last Name
Institution

Connection

Search Results to Ajaypal Singh

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Singh, Ajaypal

Item TypeName
Concept Hemoglobins
Academic Article The benefits of IV iron therapy in treating anemia in patients with renal disease and comorbid cardiovascular disease.
Academic Article Correction of anemia with epoetin alfa in chronic kidney disease.
Academic Article The target hemoglobin in patients with chronic kidney disease.
Academic Article Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients' Response to IV Iron with Elevated Ferritin (DRIVE) Study.
Academic Article The FDA black box for EPO: what should nephrologists do?
Academic Article Anemia of chronic kidney disease: CHOIR and the FDA.
Academic Article Hemoglobin maintenance with use of extended dosing of epoetin alfa in patients with diabetes and anemia of chronic kidney disease.
Academic Article Is it time to reconsider subcutaneous administration of epoetin?
Academic Article Reducing versus discontinuing erythropoietin at high hemoglobin levels.
Academic Article Ferric gluconate reduces epoetin requirements in hemodialysis patients with elevated ferritin.
Academic Article The optimal hemoglobin in dialysis patients- a critical review.
Academic Article Managing anemia in dialysis patients: hemoglobin cycling and overshoot.
Academic Article Iron deficiency in non-dialysis chronic kidney disease.
Academic Article Secondary analysis of the CHOIR trial epoetin-alpha dose and achieved hemoglobin outcomes.
Academic Article Hemoglobin target in chronic kidney disease: a pediatric perspective.
Academic Article The controversy surrounding hemoglobin and erythropoiesis-stimulating agents: what should we do now?
Academic Article Ferric gluconate treatment provides cost savings in patients with high ferritin and low transferrin saturation.
Academic Article Resolved: Targeting a higher hemoglobin is associated with greater risk in patients with CKD anemia: pro.
Academic Article Anemia management and association of race with mortality and hospitalization in a large not-for-profit dialysis organization.
Academic Article A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease.
Academic Article A secondary analysis of the CHOIR trial shows that comorbid conditions differentially affect outcomes during anemia treatment.
Academic Article Does TREAT give the boot to ESAs in the treatment of CKD anemia?
Academic Article The FDA's perspective on the risk for rapid rise in hemoglobin in treating CKD anemia: Quo Vadis.
Academic Article Should we keep hemoglobin levels as a viable outcome measure?
Academic Article Debate: PRO Position. Should hemoglobin targets for anemic patients with chronic kidney disease be changed?
Academic Article What is causing the mortality in treating the anemia of chronic kidney disease: erythropoietin dose or hemoglobin level?
Academic Article Erythropoietic response and outcomes in kidney disease and type 2 diabetes.
Academic Article Modulation of platelet activation in chronic kidney disease patients on erythropoiesis-stimulating agents.
Academic Article Effect of hemoglobin target on progression of kidney disease: a secondary analysis of the CHOIR (Correction of Hemoglobin and Outcomes in Renal Insufficiency) trial.
Academic Article Hemoglobin stability in patients with anemia, CKD, and type 2 diabetes: an analysis of the TREAT (Trial to Reduce Cardiovascular Events With Aranesp Therapy) placebo arm.
Academic Article Cardiovascular toxicity of epoetin-alfa in patients with chronic kidney disease.
Academic Article Ferric pyrophosphate citrate (Trifericâ„¢) administration via the dialysate maintains hemoglobin and iron balance in chronic hemodialysis patients.
Academic Article A Comparison of the Safety and Efficacy of HX575 (Epoetin Alfa Proposed Biosimilar) with Epoetin Alfa in Patients with End-Stage Renal Disease.
Academic Article Change in Hemoglobin Trajectory and Darbepoetin Dose Approaching End-Stage Renal Disease: Data from the Trial to Reduce Cardiovascular Events with Aranesp Therapy Trial.
Academic Article Study design and baseline characteristics of patients on dialysis in the ASCEND-D trial.
Academic Article Daprodustat for the Treatment of Anemia in Patients Undergoing Dialysis.
Academic Article Daprodustat for the Treatment of Anemia in Patients Not Undergoing Dialysis.
Academic Article Efficacy and Safety of Daprodustat for Treatment of Anemia of Chronic Kidney Disease in Incident Dialysis Patients: A Randomized Clinical Trial.

Search Criteria
  • Hemoglobins